Cargando…
A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers
Hypermethylation of CpG islands in the promoter region of tumor suppressor genes (TSGs) and their subsequent silencing is thought to be one of the main mechanisms of carcinogenesis. MBD2b enrichment coupled with a NimbleGen array was applied to examine the genome-wide CpG island methylation profile...
Autores principales: | Yang, Yuan, Zhao, Linghao, Huang, Bo, Hou, Guojun, Zhou, Beibei, Qian, Jin, Yuan, Shengxian, Xiao, Huasheng, Li, Minghui, Zhou, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394454/ https://www.ncbi.nlm.nih.gov/pubmed/28418032 http://dx.doi.org/10.1038/srep46533 |
Ejemplares similares
-
Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma
por: Hou, Guojun, et al.
Publicado: (2016) -
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334
por: Sun, Dapeng, et al.
Publicado: (2022) -
EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis
por: Gu, Fangming, et al.
Publicado: (2019) -
Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma
por: Song, Min-Ae, et al.
Publicado: (2013) -
An aberrant DNA methylation signature for predicting hepatocellular carcinoma
por: Zhang, Renhua, et al.
Publicado: (2020)